Company: CYTK
Filing Date: 2025-09-02
Form Type: 8-K
Source: 0000950170-25-112564
Chunk: 0

Company: CYTOKINETICS INC
Filing Date: 2025-09-02
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01 Other Events.

Cytokinetics, Incorporated announced that the primary results of MAPLE-HCM (Metoprolol vs Aficamten in Patients with LVOT Obstruction on Exercise Capacity in HCM) were presented in a Hot Line Session at the European Society of Cardiology Congress 2025 in Madrid, Spain, and simultaneously published in The New England Journal of Medicine. The full text of the press release issued in connection with this announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.